SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026

EPS (Basic) of -$0.69 in Q1 FY2026

Q1 FY2026 EPS (Basic) was -$0.69.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 3 analysts of -$2.27 (-91.1%) for the fiscal year ending Dec 2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$0.69-81.6% QoQ
Last fiscal yearDec 2025
-$1.19— YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year—-91.1%—
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(1.19) USD
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
SGP Competitors
EPS (Basic) for SGP and competitors
Company Period LTM YoY 3-year CAGR
ALCAlcon Inc.LTM Sep 2026$1.36 USD-35.8%+43.0%
STAASTAAR Surgical CompanyLTM Apr 2026-$0.42 USD+70.8%—
BLCOBausch + Lomb CorporationLTM Jun 2026-$0.48 USD+38.5%—
SGHTSight Sciences, Inc.LTM Mar 2026-$0.71 USD+27.7%—
RXSTRxSight, Inc.LTM Mar 2026-$1.13 USD-68.7%—
SGPSpyGlass Pharma, Inc. Common StockFY2025-$1.19 USD——
OCULOcular Therapeutix, Inc.LTM Mar 2026-$1.46 USD-27.0%—
OCSOculis Holding AGLTM Mar 2026-CHF 1.73 CHF+27.0%—
GKOSGlaukos CorporationLTM Jun 2026-$3.25 USD-97.0%—
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026-$3.5 USD-45.2%—
Peer median (excluding SGP) —-27.0%+43.0%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.